(Total Views: 367)
Posted On: 04/13/2020 10:45:18 AM
Post# of 145254
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
CNBC still only reporting on remdesivir and ANY other drug that is no where close to being ready -- including baking soda (</sarcasm>
.
WTF?
Why are they ignoring leronlimab?
And why doesn't the stock have any price support?
This is maddening.
![](/m/images/icons/icon_wink.gif)
WTF?
Why are they ignoring leronlimab?
And why doesn't the stock have any price support?
This is maddening.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)